Zobrazeno 21 - 30
of 45
pro vyhledávání: '"Shafia Rahman"'
Autor:
Ladan Golestaneh, Morayma Reyes-Gil, Lindsay Stahl, James Szymanski, Yungtai Lo, Mohammad Barouqa, Eran Bellin, Shafia Rahman, Henny H. Billett, Kenji Ikemura, Margarita Kushnir, Jesus D. Gonzalez-Lugo
Publikováno v:
Thrombosis and Haemostasis
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has been proposed as therapy to decrease mortality, often adjusted for illness sever
Publikováno v:
Blood. 138:1070-1070
Introduction: DOACs are absorbed in the gastrointestinal (GI) tract and DOAC elimination is primarily through the GI and genitourinary (GU) systems. The safety of DOACs in cancer associated thrombosis in subjects with malignant lesions in GI and GU m
Autor:
Lizamarie Bachier-Rodriguez, R. Alejandro Sica, Yanhua Wang, B. Hilda Ye, Noah Kornblum, Ana Acuna-Villaorduna, Kira Gritsman, Katharine McNeill, Fariha Khatun, Aditi Shastri, Jennat Mustafa, Amit Verma, Shafia Rahman, Urvi A Shah, Murali Janakiram, Olga Derman, Riya Patel, Ioannis Mantzaris, Alyssa De Castro, Nishi Shah, Shira E. Slasky, Mendel Goldfinger, Ulrich Steidl, Amanda Lombardo, Ira Braunschweig, Astha Thakkar, Latoya Townsend Nugent, Diego Adrianzen Herrera
Publikováno v:
Blood. 138:1400-1400
Introduction: North American-ATLL (NA-ATLL) is a distinct genomic and clinical entity when compared with Japanese ATLL. Despite the frequent CNS involvement by this entity there are no prognostication tools to identify variables associated with highe
Autor:
Diana De Oliveira, David Geller, Bang H. Hoang, Shalom Frager, Rui Yang, Shafia Rahman, Luca Paoluzzi, Jellyana Peraza, Jiani Chai, Marcel Yibirin, Andrew Mekaiel
Publikováno v:
American Journal of Gastroenterology. 116:S1120-S1120
Autor:
Christopher Nishimura, Donika Binakaj, Yang Shi, Lizamarie Bachier-Rodriguez, Carlo Palesi, Ulrich Steidl, Amanda Lombardo, Noah Kornblum, Xiaoxin Ren, Randin Nelson, Susan Sakalian, Fariha Khatun, Ira Braunschweig, Alyssa De Castro, Karen Fehn, Margaret McCort, Mendel Goldfinger, Murali Janakiram, Latoya Townsend-Nugent, Stephen Peeke, Zhu Cui, Rachel Bartash, Felisha Joseph, Ioannis Mantzaris, Rosmi Mathew, Monika Paroder, Kailyn Gillick, Anjali Naik, Yanhua Wang, Kira Gritsman, Nicole Chambers, Nishi Shah, Shafia Rahman, Kith Pradhan, Michelly Abreu, Joan Uehlinger, R. Alejandro Sica, Olga Derman, Astha Thakkar, Aditi Shastri, Karen Wright, Jennat Mustafa, Yoram A. Puius, Richard Elkind, Hao Wang, Xingxing Zang, Angelica D'Aiello, Amit Verma
Publikováno v:
Stem Cell Investig
BACKGROUND: Adoptive immunotherapy using CD19-targeted Chimeric antigen receptor T cells (CAR-T) has revolutionized the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Data is limited on the propensity of infections and lympho
Autor:
Joseph A. Sparano, Y. Goldstein, Kith Pradhan, Stuart Packer, Benjamin A. Gartrell, Niyati Goradia, Amit Verma, Lauren C. Shapiro, So Yeon Kim, Lucia Wolgast, Astha Thakkar, R. Alejandro Sica, Brian Ko, Roman Perez-Soler, Margaret E McCort, Sanjay Goel, Radhika Gali, Della F. Makower, Jesus D. Gonzalez-Lugo, Balazs Halmos, Lizamarie Bachier-Rodriguez, Shafia Rahman, Noah Kornblum
Publikováno v:
Cancer Cell
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we determined a high seroconversion rate (94%) in 200 patients with cancer in New Yo
Autor:
Mendel Goldfinger, Fariha Khatun, B. Hilda Ye, Felisha Joseph, Alvaro Alvarez Soto, Angelica D'Aiello, Shafia Rahman, Noah Kornblum, Ira Braunschweig, Anjali Naik, Kira Gritsman, Kith Pradhan, Kenny Ye, Amit Verma, Alyssa De Castro, Xingxing Zang, Zhu Cui, Olga Derman, Urvi A Shah, R. Alejandro Sica, Michal Kasher Meron, Lindor Qunaj, Kailyn Gillick, Hao Wang, Ioannis Mantzaris, Murali Janakiram, Astha Thakkar, Xiaoxin Ren, Aditi Shastri, Jennat Mustafa, Ulrich Steidl, Amanda Lombardo
Publikováno v:
Blood. 136:38-39
Introduction: Adult T cell leukemia lymphoma (ATLL) is a rare T cell neoplasm caused by the human T-lymphotropic virus (HTLV-1) virus. Although there are indolent subtypes it is often a highly aggressive and chemotherapy refractory malignancy. We fol
Autor:
L. Townsend Nugent, N. Chambers, Anjali Naik, Kira Gritsman, Fariha Khatun, Mendel Goldfinger, Noah Kornblum, Astha Thakkar, Kailyn Gillick, B. H. Ye, Carlo Palesi, R. Yusay, H. Noicely, Shafia Rahman, Murali Janakiram, Lizamarie Bachier-Rodriguez, Ioannis Mantzaris, D. Binakaj, Olga Derman, Ira Braunschweig, Zhu Cui, R. A. Sica, Felisha Joseph, Amit Verma, D. Adrianzen Herrera, R. Mathew, Randin Nelson, Ulrich Steidl, Amanda Lombardo, M. Abreu, Angelica D'Aiello, Aditi Shastri, Jennat Mustafa, Richard Elkind
Publikováno v:
Blood. 136:21-22
Introduction: Adult T-cell leukemia lymphoma (ATLL) is a rare hematologic malignancy caused by human T-cell lymphotropic virus (HTLV-1) with dismal cure rates and poor response to conventional chemotherapy. Allogeneic Hematopoietic Stem Cell Transpla
Autor:
Stephen Peeke, Xiaoxin Ren, Lizamarie Bachier-Rodriguez, Carlo Palesi, Joan Uehlinger, Ioannis Mantzaris, Monika Paroder, Fariha Khatun, R. Alejandro Sica, Karen Fehn, Karen Wright, Alyssa DeCastro, Murali Janakiram, Shafia Rahman, Randin Nelson, Amit Verma, Richard Elkind, Susan Sakalian, Ira Braunschweig, Christopher Nishimura, Mendel Goldfinger, Yang Shi, Zhu Cui, Anjali Naik, Aditi Shastri, Kailyn Gillick, Hao Wang, Yoram A. Puius, Kira Gritsman, Astha Thakkar, Latoya Townsend-Nugent, Angelica D'Aiello, Noah Kornblum, Yanhua Wang, Margaret E McCort, Rachel Bartash, Donika Binakaj, Felisha Joseph, Rosmi Mathew, Ryann Quinn, Ulrich Steidl, Amanda Lombardo, Nicole Chambers, Michelly Abreu, Olga Derman, Xingxing Zang, Nishi Shah
Publikováno v:
Blood. 136:10-11
Background: Adoptive immunotherapy using CD19-targeted Chimeric Antigen Receptor T-cells (CAR-T) has revolutionized the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). We have demonstrated the efficacy of FDA-approved axicabta
Effect of Medicaid expansion on incidence of early-onset colorectal cancer incidence among Hispanics
Publikováno v:
Journal of Clinical Oncology. 39:3547-3547
3547 Background: Early onset colorectal cancer (EO-CRC, age < 50 years) is an emerging public health crisis; especially in Hispanics. Access to healthcare is critical for timely detection and is tied to medical insurance. In 2010, the Affordable Care